Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Alonso

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Oncotarget|March 13, 2016
Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technologyMaider Ibarrola-Villava, Tania Fleitas, Marta J Llorca-Cardeñosa, et al.
Neurogenetics|December 31, 2013
Founder effect and ancestral origin of the spinocerebellar ataxia type 7 (SCA7) mutation in Mexican familiesLizbeth E García-Velázquez, Samuel Canizales-Quinteros, Sandra Romero-Hidalgo, et al.
International Journal of Molecular Sciences|October 16, 2024
Differential Protein Expression in Extracellular Vesicles Defines Treatment Responders and Non-Responders in Multiple SclerosisGabriel Torres Iglesias, MariPaz López-Molina, Lucía Botella, et al.
Seizure|June 26, 2012
Novel Myoclonin1/EFHC1 mutations in Mexican patients with juvenile myoclonic epilepsyAurelio Jara-Prado, Iris E Martínez-Juárez, Adriana Ochoa, et al.
Journal of the Neurological Sciences|March 6, 2016
Synaptotagmin XI in Parkinson's disease: New evidence from an association study in Spain and MexicoAngel Sesar, Pilar Cacheiro, Marisol López-López, et al.
Cancers|February 14, 2020
HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young WomenSara S Oltra, Juan Miguel Cejalvo, Eduardo Tormo, et al.
Stem Cell Research & Therapy|February 21, 2020
Low dose of extracellular vesicles identified that promote recovery after ischemic strokeLaura Otero-Ortega, Fernando Laso-García, Mari Carmen Gómez-de Frutos, et al.
Molecular Systems Biology|December 17, 2016
Disentangling genetic and epigenetic determinants of ultrafast adaptationArne B Gjuvsland, Enikö Zörgö, Jeevan Ka Samy, et al.
Journal of Neurology|April 5, 2024
Keeping prior anticoagulation treatment in the acute phase of ischaemic stroke: the REKOALA studyRicardo Rigual, Jorge Rodríguez-Pardo, Manuel Lorenzo-Diéguez, et al.
Frontiers in Oncology|October 5, 2020
MicroRNA-33b Suppresses Epithelial-Mesenchymal Transition Repressing the MYC-EZH2 Pathway in HER2+ Breast CarcinomaBirlipta Pattanayak, Iris Garrido-Cano, Anna Adam-Artigues, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Oncotarget|March 13, 2016
Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technologyMaider Ibarrola-Villava, Tania Fleitas, Marta J Llorca-Cardeñosa, et al.
Neurogenetics|December 31, 2013
Founder effect and ancestral origin of the spinocerebellar ataxia type 7 (SCA7) mutation in Mexican familiesLizbeth E García-Velázquez, Samuel Canizales-Quinteros, Sandra Romero-Hidalgo, et al.
International Journal of Molecular Sciences|October 16, 2024
Differential Protein Expression in Extracellular Vesicles Defines Treatment Responders and Non-Responders in Multiple SclerosisGabriel Torres Iglesias, MariPaz López-Molina, Lucía Botella, et al.
Seizure|June 26, 2012
Novel Myoclonin1/EFHC1 mutations in Mexican patients with juvenile myoclonic epilepsyAurelio Jara-Prado, Iris E Martínez-Juárez, Adriana Ochoa, et al.
Journal of the Neurological Sciences|March 6, 2016
Synaptotagmin XI in Parkinson's disease: New evidence from an association study in Spain and MexicoAngel Sesar, Pilar Cacheiro, Marisol López-López, et al.
Cancers|February 14, 2020
HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young WomenSara S Oltra, Juan Miguel Cejalvo, Eduardo Tormo, et al.
Stem Cell Research & Therapy|February 21, 2020
Low dose of extracellular vesicles identified that promote recovery after ischemic strokeLaura Otero-Ortega, Fernando Laso-García, Mari Carmen Gómez-de Frutos, et al.
Molecular Systems Biology|December 17, 2016
Disentangling genetic and epigenetic determinants of ultrafast adaptationArne B Gjuvsland, Enikö Zörgö, Jeevan Ka Samy, et al.
Journal of Neurology|April 5, 2024
Keeping prior anticoagulation treatment in the acute phase of ischaemic stroke: the REKOALA studyRicardo Rigual, Jorge Rodríguez-Pardo, Manuel Lorenzo-Diéguez, et al.
Frontiers in Oncology|October 5, 2020
MicroRNA-33b Suppresses Epithelial-Mesenchymal Transition Repressing the MYC-EZH2 Pathway in HER2+ Breast CarcinomaBirlipta Pattanayak, Iris Garrido-Cano, Anna Adam-Artigues, et al.
Pageof 11